Enzymatic reactions in the presence of keto acids
View Patent ↗Conversion in vitro of X-Gly to X-alpha-hydroxy-Gly or X—NH 2 (X being a peptide or any other compound having a carbonyl group capable of forming a covalent bond with glycine) is accomplished enzymatically in the presence of keto acids, or salts or esters thereof, to provide a good yield without the necessity of catalase or similar enzymatic reaction enhancers. Peptidylglycine α-amidating monooxygenase (PAM) is a preferred enzyme for catalyzing the conversion. Alternatively, peptidylglycine α-hydroxylating monooxygenase (PHM) is utilized to convert X-Gly to X-alpha-hydroxy-Gly which may be recovered, or optionally may be simultaneously or sequentially converted to an amide by either a Lewis base or action of the enzyme peptidyl α-hydroxyglycine α-amidating lyase (PAL). Both PHM and PAL are functional domains of PAM.
1. A method for the in vitro production of an amidated product, said method comprising reacting a precursor having a glycine residue, in free acid form and attached to a carbonyl group, in the presence of (A) peptidylglycine alpha-amidating monooxygenase and (B) a reaction-enhancing compound that is an alpha-keto acid, or salt or ester therof, wherein said alpha-keto acid has the molecular structure RC(O)C(O)OH, and wherein R is selected from the group consisting of aryl, a C1-C4 hydrocarbon moiety, a halogenated or hydroxylated C1-C4 hydrocarbon moiety, and a C1-C4 carboxylic acid.
2. The method of claim 1 wherein said reaction-enhancing compound is an alpha-keto acid salt.
3. The method of claim 1 wherein said reaction-enhancing compound is an alpha-keto acid ester.
4. The method of claim 1 wherein said reaction-enhancing compound is an alpha-keto acid.
5. The method of claim 1 wherein R is aryl.
6. The method of claim 5 wherein R is phenyl.
7. The method of claim 1 wherein R is a C1-C4 hydrocarbon.
8. The method of claim 1 wherein R is a C1-C4 alkyl.
9. The method of claim 1 wherein said reaction-enhancing compound is selected from the group consisting of ethyl pyruvate, pyruvic acid or salt thereof, methyl pyruvate, benzoyl formic acid or salt thereof, 2-ketobutyric acid or salt thereof, 3-methyl-2-oxobutanoic acid or salt thereof, and 2-keto glutaric acid or salt thereof.
10. The method of claim 1 wherein said reaction enhancing compound is selected from the group consisting pyruvic acid and sodium pyruvate.
11. A method for the in vitro production of an amidated product said method comprising:
(A) forming a hydroxylated intermediate by reacting a precursor having a glycine residue, in free acid form and attached to a carbonyl group, in the presence of (i) peptidylglycine alpha-hydroxylating monooxygenase and (ii) a reaction-enhancing compound that is an alpha-keto acid, or salt or ester thereof, wherein said alpha-keto acid has the molecular structure RC(O)C(O)OH, and wherein R is selected from the group consisting of aryl, a C1-C4 hydrocarbon moiety, a halogenated or hydroxylated C1-C4 hydrocarbon moiety, and a C1-C4 carboxylic acid; and
(B) simultaneously or subsequently reacting said intermediate with either a Lewis base or peptidyl alpha-hydroxyglycine alpha-amidating lyase.
12. The method of claim 11 wherein said reaction-enhancing compound is an alpha-keto acid salt.
13. The method of claim 11 wherein said reaction-enhancing compound is an alpha-keto acid ester.
14. The method of claim 11 wherein said reaction-enhancing compound is an alpha-keto acid.
15. The method of claim 11 wherein R is aryl.
16. The method of claim 15 wherein R is phenyl.
17. The method of claim 11 wherein R is a C1-C4 hydrocarbon.
18. The method of claim 11 wherein R is a C1-C4 alkyl.
19. The method of claim 11 wherein said reaction-enhancing compound is selected from the group consisting of ethyl pyruvate, pyruvic acid or salt thereof, methyl pyruvate, benzoyl formic acid or salt thereof, 2-ketobutyric acid or salt thereof, 3-methyl-2-oxobutanoic acid or salt thereof, and 2-keto glutaric acid or salt thereof.
20. The method of claim 11 wherein said reaction enhancing compound is selected from the group consisting of pyruvic acid and sodium pyruvate.
21. The method of claim 1 wherein said product is an amidated analog of a natural peptide that is not naturally amidated.
22. The method of claim 11 wherein said product is an amidated analog of a natural peptide that is not naturally amidated.
23. The method of claim 1 wherein said product is an analog of a naturally amidated peptide that is additionally amidated at a location where said natural peptide is not amidated.
24. The method of claim 11 wherein said product is an analog of a naturally amidated peptide that is additionally amidated at a location where said natural peptide is not amidated.
25. A method for enhancing the bioavailability of a peptide pharmaceutical agent wherein said agent is amidated at a location that is not naturally amidated, said non-natural amidation being accomplished by reacting a precursor having a glycine residue, in free acid, form at a position where amidation is desired in the presence of (A) peptidylglycine alpha-amidating monooxygenase and (B) a reaction-enhancing compound that is an alpha-keto acid, or salt or ester therof, wherein said alpha-keto acid has the molecular structure RC(O)C(O)OH, and wherein R is selected from the group consisting of aryl, a C1-C4 hydrocarbon moiety, a halogenated or hydroxylated C1-C4 hydrocarbon moiety, and a C1-C4 carboxylic acid.
26. A method for enhancing the bioavailability of a peptide pharmaceutical agent wherein said agent is amidated at a location that is not naturally amidated, said non-natural amidation being accomplished by (A) reacting a precursor having a glycine residue, in free acid form and attached to a carbonyl group at a position where amidation is desired, in the presence of (i) peptidylglycine alpha-hydroxylating monooxygenase and (ii) a reaction-enhancing compound that is an alpha-keto acid, or salt or ester therof, wherein said alpha-keto acid has the molecular structure RC(O)C(O)OH, and wherein R is selected from the group consisting of aryl, a C1-C4 hydrocarbon moiety, a halogenated or hydroxylated C1-C4 hydrocarbon moiety, and a C1-C4 carboxylic acid, thus forming a hydroxylated intermediate; and
(B) simultaneously or subsequently reacting said intermediate with either a Lewis base or peptidyl alpha-hydroxyglycine alpha-amidating lyase.
27. The method of claim 1 wherein said product is a peptide.
28. The method of claim 11 wherein said product is a peptide.
29. A method for the in vitro production of an alpha-hydroxy-glycine product said method comprising reacting a precursor having a glycine residue, in free acid form and attached to a carbonyl group, in the presence of (i) peptidylglycine alpha-hydroxylating monooxygenase and (ii) a reaction-enhancing compound that is an alpha-keto acid, or salt or ester thereof, wherein said alpha-keto acid has the molecular structure RC(O)C(O)OH, and wherein R is selected from the group consisting of aryl, a C1-C4 hydrocarbon moiety, a halogenated or hydroxylated C1-C4 hydrocarbon moiety, and a C1-C4 carboxylic acid.
30. The method of claim 29 wherein said reaction-enhancing compound is an alpha-keto acid salt.
31. The method of claim 29 wherein said reaction-enhancing compound is an alpha-keto acid ester.
32. The method of claim 29 wherein said reaction-enhancing compound is an alpha-keto acid.
33. The method of claim 29 wherein R is aryl.
34. The method of claim 33 wherein R is phenyl.
35. The method of claim 29 wherein R is a C1-C4 hydrocarbon.
36. The method of claim 29 wherein R is a C1-C4 alkyl.
37. The method of claim 29 wherein said reaction-enhancing compound is selected from the group consisting of ethyl pyruvate, pyruvic acid or salt thereof, methyl pyruvate, benzoyl formic acid or salt thereof, 2-ketobutyric acid or salt thereof, 3-methyl-2-oxobutanoic acid or salt thereof, and 2-keto glutaric acid or salt thereof.
38. The method of claim 29 wherein said reaction enhancing compound is selected from the group consisting of pyruvic acid and sodium pyruvate.